Table of Content 1 Introduction 1.1 Objective of the Study 1.2 Definition of the Market 1.3 Market Scope 1.3.1 Market Segment by Type, Application and Marketing Channel 1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa) 1.4 Years Considered for the Study (2014-2026) 1.5 Currency Considered (U.S. Dollar) 1.6 Stakeholders 2 Key Findings of the Study 3 Market Dynamics 3.1 Driving Factors for this Market 3.2 Factors Challenging the Market 3.3 Opportunities of the Global Antihypertensive Drugs Market (Regions, Growing/Emerging Downstream Market Analysis) 3.4 Technological and Market Developments in the Antihypertensive Drugs Market 3.5 Industry News by Region 3.6 Regulatory Scenario by Region/Country 3.7 Market Investment Scenario Strategic Recommendations Analysis 4 Value Chain of the Antihypertensive Drugs Market 4.1 Value Chain Status 4.2 Upstream Raw Material Analysis 4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type) 4.4 Distributors/Traders 4.5 Downstream Major Customer Analysis (by Region) 5 Global Antihypertensive Drugs Market-Segmentation by Type 5.1 ARB 5.2 CCB 5.3 Other 6 Global Antihypertensive Drugs Market-Segmentation by Application 6.1 Hypertension 6.2 PAH 6.3 Other 7 Global Antihypertensive Drugs Market-Segmentation by Marketing Channel 7.1 Traditional Marketing Channel (Offline) 7.2 Online Channel 8 Competitive Intelligence – Company Profiles 8.1 Johnson & Johnson Ltd. 8.1.1 Johnson & Johnson Ltd. Profile 8.1.2 Johnson & Johnson Ltd. Sales, Growth Rate and Global Market Share from 2014-2019E 8.1.3 Johnson & Johnson Ltd. Product/Solution Launches and Enhancements Analysis 8.1.4 Johnson & Johnson Ltd. Business Overview/Recent Development/Acquisitions 8.2 Sanofi S.A. 8.2.1 Sanofi S.A. Profile 8.2.2 Sanofi S.A. Sales, Growth Rate and Global Market Share from 2014-2019E 8.2.3 Sanofi S.A. Product/Solution Launches and Enhancements Analysis 8.2.4 Sanofi S.A. Business Overview/Recent Development/Acquisitions 8.3 Ranbaxy Laboratories Limited 8.3.1 Ranbaxy Laboratories Limited Profile 8.3.2 Ranbaxy Laboratories Limited Sales, Growth Rate and Global Market Share from 2014-2019E 8.3.3 Ranbaxy Laboratories Limited Product/Solution Launches and Enhancements Analysis 8.3.4 Ranbaxy Laboratories Limited Business Overview/Recent Development/Acquisitions 8.4 Novartis AG 8.4.1 Novartis AG Profile 8.4.2 Novartis AG Sales, Growth Rate and Global Market Share from 2014-2019E 8.4.3 Novartis AG Product/Solution Launches and Enhancements Analysis 8.4.4 Novartis AG Business Overview/Recent Development/Acquisitions 8.5 Takeda Pharmaceutical Company Limited 8.5.1 Takeda Pharmaceutical Company Limited Profile 8.5.2 Takeda Pharmaceutical Company Limited Sales, Growth Rate and Global Market Share from 2014-2019E 8.5.3 Takeda Pharmaceutical Company Limited Product/Solution Launches and Enhancements Analysis 8.5.4 Takeda Pharmaceutical Company Limited Business Overview/Recent Development/Acquisitions 8.6 Daiichi Sankyo Company Limited 8.6.1 Daiichi Sankyo Company Limited Profile 8.6.2 Daiichi Sankyo Company Limited Sales, Growth Rate and Global Market Share from 2014-2019E 8.6.3 Daiichi Sankyo Company Limited Product/Solution Launches and Enhancements Analysis 8.6.4 Daiichi Sankyo Company Limited Business Overview/Recent Development/Acquisitions 8.7 Merck & Co., Inc. 8.7.1 Merck & Co., Inc. Profile 8.7.2 Merck & Co., Inc. Sales, Growth Rate and Global Market Share from 2014-2019E 8.7.3 Merck & Co., Inc. Product/Solution Launches and Enhancements Analysis 8.7.4 Merck & Co., Inc. Business Overview/Recent Development/Acquisitions 8.8 Pfizer, Inc. 8.8.1 Pfizer, Inc. Profile 8.8.2 Pfizer, Inc. Sales, Growth Rate and Global Market Share from 2014-2019E 8.8.3 Pfizer, Inc. Product/Solution Launches and Enhancements Analysis 8.8.4 Pfizer, Inc. Business Overview/Recent Development/Acquisitions 8.9 Lupin Limited 8.9.1 Lupin Limited Profile 8.9.2 Lupin Limited Sales, Growth Rate and Global Market Share from 2014-2019E 8.9.3 Lupin Limited Product/Solution Launches and Enhancements Analysis 8.9.4 Lupin Limited Business Overview/Recent Development/Acquisitions 8.10 Astra Zeneca Plc 8.10.1 Astra Zeneca Plc Profile 8.10.2 Astra Zeneca Plc Sales, Growth Rate and Global Market Share from 2014-2019E 8.10.3 Astra Zeneca Plc Product/Solution Launches and Enhancements Analysis 8.10.4 Astra Zeneca Plc Business Overview/Recent Development/Acquisitions 8.11 Actelion Ltd. 8.11.1 Actelion Ltd. Profile 8.11.2 Actelion Ltd. Sales, Growth Rate and Global Market Share from 2014-2019E 8.11.3 Actelion Ltd. Product/Solution Launches and Enhancements Analysis 8.11.4 Actelion Ltd. Business Overview/Recent Development/Acquisitions 8.12 United Therapeutics Corp 8.12.1 United Therapeutics Corp Profile 8.12.2 United Therapeutics Corp Sales, Growth Rate and Global Market Share from 2014-2019E 8.12.3 United Therapeutics Corp Product/Solution Launches and Enhancements Analysis 8.12.4 United Therapeutics Corp Business Overview/Recent Development/Acquisitions 9 Global Antihypertensive Drugs Market-Segmentation by Geography 10 North America 10.1 North America Antihypertensive Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 10.2 North America Antihypertensive Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 10.3 North America Antihypertensive Drugs Production Analysis from 2014-2019E 10.4 North America Antihypertensive Drugs Consumption Analysis from 2014-2019E 10.5 North America Antihypertensive Drugs Import and Export from 2014-2019E 10.6 North America Antihypertensive Drugs Value, Production and Market Share by Type (2014-2019E) 10.7 North America Antihypertensive Drugs Consumption, Value and Market Share by Application (2014-2019E) 10.8 North America Antihypertensive Drugs by Country (United States, Canada) 10.8.1 North America Antihypertensive Drugs Sales by Country (2014-2019E) 10.8.2 North America Antihypertensive Drugs Consumption Value by Country (2014-2019E) 10.9 North America Antihypertensive Drugs Market PEST Analysis 11 Europe 11.1 Europe Antihypertensive Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 11.2 Europe Antihypertensive Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 11.3 Europe Antihypertensive Drugs Production Analysis from 2014-2019E 11.4 Europe Antihypertensive Drugs Consumption Analysis from 2014-2019E 11.5 Europe Antihypertensive Drugs Import and Export from 2014-2019E 11.6 Europe Antihypertensive Drugs Value, Production and Market Share by Type (2014-2019E) 11.7 Europe Antihypertensive Drugs Consumption, Value and Market Share by Application (2014-2019E) 11.8 Europe Antihypertensive Drugs by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium) 11.8.1 Europe Antihypertensive Drugs Sales by Country (2014-2019E) 11.8.2 Europe Antihypertensive Drugs Consumption Value by Country (2014-2019E) 11.9 Europe Antihypertensive Drugs Market PEST Analysis 12 Asia-Pacific 12.1 Asia-Pacific Antihypertensive Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 12.2 Asia-Pacific Antihypertensive Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 12.3 Asia-Pacific Antihypertensive Drugs Production Analysis from 2014-2019E 12.4 Asia-Pacific Antihypertensive Drugs Consumption Analysis from 2014-2019E 12.5 Asia-Pacific Antihypertensive Drugs Import and Export from 2014-2019E 12.6 Asia-Pacific Antihypertensive Drugs Value, Production and Market Share by Type (2014-2019E) 12.7 Asia-Pacific Antihypertensive Drugs Consumption, Value and Market Share by Application (2014-2019E) 12.8 Asia-Pacific Antihypertensive Drugs by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia) 12.8.1 Asia-Pacific Antihypertensive Drugs Sales by Country (2014-2019E) 12.8.2 Asia-Pacific Antihypertensive Drugs Consumption Value by Country (2014-2019E) 12.9 Asia-Pacific Antihypertensive Drugs Market PEST Analysis 13 Latin America 13.1 Latin America Antihypertensive Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 13.2 Latin America Antihypertensive Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 13.3 Latin America Antihypertensive Drugs Production Analysis from 2014-2019E 13.4 Latin America Antihypertensive Drugs Consumption Analysis from 2014-2019E 13.5 Latin America Antihypertensive Drugs Import and Export from 2014-2019E 13.6 Latin America Antihypertensive Drugs Value, Production and Market Share by Type (2014-2019E) 13.7 Latin America Antihypertensive Drugs Consumption, Value and Market Share by Application (2014-2019E) 13.8 Latin America Antihypertensive Drugs by Country (Brazil, Mexico, Argentina, Columbia, Chile) 13.8.1 Latin America Antihypertensive Drugs Sales by Country (2014-2019E) 13.8.2 Latin America Antihypertensive Drugs Consumption Value by Country (2014-2019E) 13.9 Latin America Antihypertensive Drugs Market PEST Analysis 14 Middle East & Africa 14.1 Middle East & Africa Antihypertensive Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 14.2 Middle East & Africa Antihypertensive Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 14.3 Middle East & Africa Antihypertensive Drugs Production Analysis from 2014-2019E 14.4 Middle East & Africa Antihypertensive Drugs Consumption Analysis from 2014-2019E 14.5 Middle East & Africa Antihypertensive Drugs Import and Export from 2014-2019E 14.6 Middle East & Africa Antihypertensive Drugs Value, Production and Market Share by Type (2014-2019E) 14.7 Middle East & Africa Antihypertensive Drugs Consumption, Value and Market Share by Application (2014-2019E) 14.8 Middle East & Africa Antihypertensive Drugs by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa) 14.8.1 Middle East & Africa Antihypertensive Drugs Sales by Country (2014-2019E) 14.8.2 Middle East & Africa Antihypertensive Drugs Consumption Value by Country (2014-2019E) 14.9 Middle East & Africa Antihypertensive Drugs Market PEST Analysis 15 Future Forecast of the Global Antihypertensive Drugs Market from 2018-2026 15.1 Future Forecast of the Global Antihypertensive Drugs Market from 2019-2026 Segment by Region 15.2 Global Antihypertensive Drugs Production and Growth Rate Forecast by Type (2019-2026) 15.3 Global Antihypertensive Drugs Consumption and Growth Rate Forecast by Application (2019-2026) 16 Appendix 16.1 Methodology 16.2 Research Data Source

List of Tables and Figures Global Antihypertensive Drugs Market Value ($) and Growth Rate of Antihypertensive Drugs from 2014-2026 Global Antihypertensive Drugs Production and Growth Rate Segment by Product Type from 2014-2026F Global Antihypertensive Drugs Consumption and Growth Rate Segment by Application from 2014-2019E Figure Antihypertensive Drugs Picture Table Product Specifications of Antihypertensive Drugs Table Driving Factors for this Market Table Industry News of Antihypertensive Drugs Market Figure Value Chain Status of Antihypertensive Drugs Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type) Table Distributors/Traders Table Downstream Major Customer Analysis (by Region, by Preference) Table Global Antihypertensive Drugs Production and Growth Rate Segment by Product Type from 2014-2019E Table Global Antihypertensive Drugs Value ($) and Growth Rate Segment by Product Type from 2014-2019E Figure ARB of Antihypertensive Drugs Figure CCB of Antihypertensive Drugs Figure Other of Antihypertensive Drugs Table Global Antihypertensive Drugs Consumption and Growth Rate Segment by Application from 2014-2019E Table Global Antihypertensive Drugs Value ($) and Growth Rate Segment by Application from 2014-2019E Figure Hypertension of Antihypertensive Drugs Figure PAH of Antihypertensive Drugs Figure Other of Antihypertensive Drugs Table Global Antihypertensive Drugs Consumption and Growth Rate Segment by Marketing Channel from 2014-2019E Table Global Antihypertensive Drugs Value ($) and Growth Rate Segment by Marketing Channel from 2014-2019E Figure Traditional Marketing Channel (Offline) of Antihypertensive Drugs Figure Online Channel of Antihypertensive Drugs Table Johnson & Johnson Ltd. Profile (Company Name, Plants Distribution, Sales Region) Figure Johnson & Johnson Ltd. Sales and Growth Rate from 2014-2019E Figure Johnson & Johnson Ltd. Revenue ($) and Global Market Share from 2014-2019E Table Johnson & Johnson Ltd. Antihypertensive Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Sanofi S.A. Profile (Company Name, Plants Distribution, Sales Region) Figure Sanofi S.A. Sales and Growth Rate from 2014-2019E Figure Sanofi S.A. Revenue ($) and Global Market Share from 2014-2019E Table Sanofi S.A. Antihypertensive Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Ranbaxy Laboratories Limited Profile (Company Name, Plants Distribution, Sales Region) Figure Ranbaxy Laboratories Limited Sales and Growth Rate from 2014-2019E Figure Ranbaxy Laboratories Limited Revenue ($) and Global Market Share from 2014-2019E Table Ranbaxy Laboratories Limited Antihypertensive Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Novartis AG Profile (Company Name, Plants Distribution, Sales Region) Figure Novartis AG Sales and Growth Rate from 2014-2019E Figure Novartis AG Revenue ($) and Global Market Share from 2014-2019E Table Novartis AG Antihypertensive Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Takeda Pharmaceutical Company Limited Profile (Company Name, Plants Distribution, Sales Region) Figure Takeda Pharmaceutical Company Limited Sales and Growth Rate from 2014-2019E Figure Takeda Pharmaceutical Company Limited Revenue ($) and Global Market Share from 2014-2019E Table Takeda Pharmaceutical Company Limited Antihypertensive Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Daiichi Sankyo Company Limited Profile (Company Name, Plants Distribution, Sales Region) Figure Daiichi Sankyo Company Limited Sales and Growth Rate from 2014-2019E Figure Daiichi Sankyo Company Limited Revenue ($) and Global Market Share from 2014-2019E Table Daiichi Sankyo Company Limited Antihypertensive Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Merck & Co., Inc. Profile (Company Name, Plants Distribution, Sales Region) Figure Merck & Co., Inc. Sales and Growth Rate from 2014-2019E Figure Merck & Co., Inc. Revenue ($) and Global Market Share from 2014-2019E Table Merck & Co., Inc. Antihypertensive Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Pfizer, Inc. Profile (Company Name, Plants Distribution, Sales Region) Figure Pfizer, Inc. Sales and Growth Rate from 2014-2019E Figure Pfizer, Inc. Revenue ($) and Global Market Share from 2014-2019E Table Pfizer, Inc. Antihypertensive Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Lupin Limited Profile (Company Name, Plants Distribution, Sales Region) Figure Lupin Limited Sales and Growth Rate from 2014-2019E Figure Lupin Limited Revenue ($) and Global Market Share from 2014-2019E Table Lupin Limited Antihypertensive Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Astra Zeneca Plc Profile (Company Name, Plants Distribution, Sales Region) Figure Astra Zeneca Plc Sales and Growth Rate from 2014-2019E Figure Astra Zeneca Plc Revenue ($) and Global Market Share from 2014-2019E Table Astra Zeneca Plc Antihypertensive Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Actelion Ltd. Profile (Company Name, Plants Distribution, Sales Region) Figure Actelion Ltd. Sales and Growth Rate from 2014-2019E Figure Actelion Ltd. Revenue ($) and Global Market Share from 2014-2019E Table Actelion Ltd. Antihypertensive Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table United Therapeutics Corp Profile (Company Name, Plants Distribution, Sales Region) Figure United Therapeutics Corp Sales and Growth Rate from 2014-2019E Figure United Therapeutics Corp Revenue ($) and Global Market Share from 2014-2019E Table United Therapeutics Corp Antihypertensive Drugs Sales, Price, Revenue, Gross Margin (2014-2019E) Table Global Antihypertensive Drugs Production Value ($) by Region from 2014-2019E Table Global Antihypertensive Drugs Production Value Share by Region from 2014-2019E Table Global Antihypertensive Drugs Production by Region from 2014-2019E Table Global Antihypertensive Drugs Consumption Value ($) by Region from 2014-2019E Table Global Antihypertensive Drugs Consumption by Region from 2014-2019E Table North America Antihypertensive Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table North America Antihypertensive Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table North America Antihypertensive Drugs Import and Export from 2014-2019E Table North America Antihypertensive Drugs Value ($) by Type (2014-2019E) Table North America Antihypertensive Drugs Production by Type (2014-2019E) Table North America Antihypertensive Drugs Consumption by Application (2014-2019E) Table North America Antihypertensive Drugs Consumption by Country (2014-2019E) Table North America Antihypertensive Drugs Consumption Value ($) by Country (2014-2019E) Figure North America Antihypertensive Drugs Market PEST Analysis Table Europe Antihypertensive Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Europe Antihypertensive Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Europe Antihypertensive Drugs Import and Export from 2014-2019E Table Europe Antihypertensive Drugs Value ($) by Type (2014-2019E) Table Europe Antihypertensive Drugs Production by Type (2014-2019E) Table Europe Antihypertensive Drugs Consumption by Application (2014-2019E) Table Europe Antihypertensive Drugs Consumption by Country (2014-2019E) Table Europe Antihypertensive Drugs Consumption Value ($) by Country (2014-2019E) Figure Europe Antihypertensive Drugs Market PEST Analysis Table Asia-Pacific Antihypertensive Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Asia-Pacific Antihypertensive Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Asia-Pacific Antihypertensive Drugs Import and Export from 2014-2019E Table Asia-Pacific Antihypertensive Drugs Value ($) by Type (2014-2019E) Table Asia-Pacific Antihypertensive Drugs Production by Type (2014-2019E) Table Asia-Pacific Antihypertensive Drugs Consumption by Application (2014-2019E) Table Asia-Pacific Antihypertensive Drugs Consumption by Country (2014-2019E) Table Asia-Pacific Antihypertensive Drugs Consumption Value ($) by Country (2014-2019E) Figure Asia-Pacific Antihypertensive Drugs Market PEST Analysis Table Latin America Antihypertensive Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Latin America Antihypertensive Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Latin America Antihypertensive Drugs Import and Export from 2014-2019E Table Latin America Antihypertensive Drugs Value ($) by Type (2014-2019E) Table Latin America Antihypertensive Drugs Production by Type (2014-2019E) Table Latin America Antihypertensive Drugs Consumption by Application (2014-2019E) Table Latin America Antihypertensive Drugs Consumption by Country (2014-2019E) Table Latin America Antihypertensive Drugs Consumption Value ($) by Country (2014-2019E) Figure Latin America Antihypertensive Drugs Market PEST Analysis Table Middle East & Africa Antihypertensive Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Middle East & Africa Antihypertensive Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Middle East & Africa Antihypertensive Drugs Import and Export from 2014-2019E Table Middle East & Africa Antihypertensive Drugs Value ($) by Type (2014-2019E) Table Middle East & Africa Antihypertensive Drugs Production by Type (2014-2019E) Table Middle East & Africa Antihypertensive Drugs Consumption by Application (2014-2019E) Table Middle East & Africa Antihypertensive Drugs Consumption by Country (2014-2019E) Table Middle East & Africa Antihypertensive Drugs Consumption Value ($) by Country (2014-2019E) Figure Middle East & Africa Antihypertensive Drugs Market PEST Analysis Table Global Antihypertensive Drugs Value ($) and Growth Rate Forecast by Region (2018-2026) Table Global Antihypertensive Drugs Production and Growth Rate Forecast by Region (2019-2026) Table Global Antihypertensive Drugs Consumption and Growth Rate Forecast by Region (2019-2026) Table Global Antihypertensive Drugs Production and Growth Rate Forecast by Type (2019-2026) Table Global Antihypertensive Drugs Consumption and Growth Rate Forecast by Application (2019-2026)